Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INTELLIGENT BIO SOLUTIONS INC. Director's Dealing 2023

Oct 10, 2023

35195_dirs_2023-10-10_bbdb6502-658e-4800-b5be-597fe4252699.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: INTELLIGENT BIO SOLUTIONS INC. (INBS)
CIK: 0001725430
Period of Report: 2023-10-04

Reporting Person: Sakiris Spiro Kevin (Chief Financial Officer)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 117472 Indirect

Footnotes

F1: On October 6, 2023, the reporting person filed a Form 4 which inadvertently reported that, following his purchase of Class A Units, he indirectly owned 117,427 shares of the issuer's common stock. In fact, as reported in this amendment, the reporting person indirectly owned 117,472 shares of common stock.

F2: These securities are held by Anest Holdings Pty Ltd, as trustee of ATF S&T Sakiris Superannuation Fund, of which Mr. Sakiris is a director.